Patient-Focused And Connected Clinical Trials: A New Rare Disease Paradigm

Source: Medrio

Patient centricity isn’t just a buzz word. It’s the key to achieving a sustainable clinical trial paradigm that reduces the burden of participation and accelerates drug development – especially in rare disease research. That’s what Scott Schliebner of the contract research organization PRA Health Sciences argued in his presentation at Medrio’s annual conference in April. Watch the video here to learn how to make clinical trials more successful and patient-focused.